Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;138:120-131.
doi: 10.1016/j.critrevonc.2019.04.010. Epub 2019 Apr 15.

Targeting Angiosarcomas of the Soft Tissues: A Challenging Effort in a Heterogeneous and Rare Disease

Affiliations
Free article
Review

Targeting Angiosarcomas of the Soft Tissues: A Challenging Effort in a Heterogeneous and Rare Disease

M E Weidema et al. Crit Rev Oncol Hematol. .
Free article

Abstract

Angiosarcomas are rare malignant tumors with a heterogeneous clinical presentation and generally poor prognosis. It has been difficult to establish consistent molecular characteristics and driver events in angiosarcoma development. Oncogenic and angiogenesis-related pathways have been investigated pre-clinically and clinically with varying results. A few promising responses to checkpoint inhibitors have been described, but immunological features require further elucidation. With this review we present an overview of the critical biological pathways and processes affected in angiosarcoma, and their potential role in novel, non-cytotoxic, systemic treatments.

Keywords: Angiogenesis; Angiosarcoma; Immunotherapy; Oncogenic pathways; Translational research.

Similar articles

See all similar articles

Cited by 1 article

LinkOut - more resources

Feedback